Literature DB >> 16129418

Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.

Yue Fu1, Leonid Buryanovskyy, Zhongtao Zhang.   

Abstract

CB1954 is a cancer pro-drug that can be activated through reduction by Escherichia coli nitro-reductases and quinone reductases. Human quinone reductase 2 is very efficient in the activation of CB1954, approximately 3000 times more efficient than human QR1 in terms of k(cat)/K(m). We have solved the three-dimensional structure of QR2 in complex with CB1954 to a nominal resolution of 1.5A. The complex structure indicates the essentiality of the two nitro groups: one nitro group forms hydrogen bonds with the side-chain of Asn161 of QR2 to hold the other nitro group in position for the reduction. We further conclude that residue 161, an Asn in QR2 and a His in QR1, is critical in differentiating the substrate specificities of these two enzymes. Mutation of Asn161 to His161 in QR2 resulted in the total loss of the enzymatic activity towards activation of CB1954, whereas the rates of reduction towards menadione are not altered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129418     DOI: 10.1016/j.bbrc.2005.08.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.

Authors:  Arup Maiti; P V Narasimha Reddy; Megan Sturdy; Laura Marler; Scott D Pegan; Andrew D Mesecar; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

2.  Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.

Authors:  P V Narasimha Reddy; Katherine C Jensen; Andrew D Mesecar; Phillip E Fanwick; Mark Cushman
Journal:  J Med Chem       Date:  2011-12-29       Impact factor: 7.446

3.  Interplay of flavin's redox states and protein dynamics: an insight from QM/MM simulations of dihydronicotinamide riboside quinone oxidoreductase 2.

Authors:  Robyn M Mueller; Michael A North; Chee Yang; Sanchita Hati; Sudeep Bhattacharyya
Journal:  J Phys Chem B       Date:  2011-03-16       Impact factor: 2.991

4.  Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS.

Authors:  Yongsoo Choi; Katherine Jermihov; Sang-Jip Nam; Megan Sturdy; Katherine Maloney; Xi Qiu; Lucas R Chadwick; Matthew Main; Shao-Nong Chen; Andrew D Mesecar; Norman R Farnsworth; Guido F Pauli; William Fenical; John M Pezzuto; Richard B van Breemen; Richard R van Breemen
Journal:  Anal Chem       Date:  2010-12-30       Impact factor: 6.986

5.  X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.

Authors:  Scott D Pegan; Megan Sturdy; Gilles Ferry; Philippe Delagrange; Jean A Boutin; Andrew D Mesecar
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

6.  Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.

Authors:  Marine Dufour; Chao Yan; David Siegel; Marie A Colucci; Matthew Jenner; Neil J Oldham; Joe Gomez; Philip Reigan; Yazhuo Li; Cristina I De Matteis; David Ross; Christopher J Moody
Journal:  Chembiochem       Date:  2011-04-19       Impact factor: 3.164

7.  Cloning, Expression, Purification, Crystallization, and X-Ray Structural Determination of the Human NQO2 in Complex with Melatonin.

Authors:  Barbara Calamini; Gilles Ferry; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

8.  Quinone reductase 2 is a catechol quinone reductase.

Authors:  Yue Fu; Leonid Buryanovskyy; Zhongtao Zhang
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

Review 9.  Azoreductases in drug metabolism.

Authors:  Ali Ryan
Journal:  Br J Pharmacol       Date:  2016-09-02       Impact factor: 8.739

10.  Activation of nitrofurazone by azoreductases: multiple activities in one enzyme.

Authors:  Ali Ryan; Elise Kaplan; Nicola Laurieri; Edward Lowe; Edith Sim
Journal:  Sci Rep       Date:  2011-08-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.